EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieÄquivalenzstudieOpen Access · CC BY-NC-ND 4.0

Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial

Yi Hu, Zhen-Yu Zhang, Fen Wang, Kun Zhuang, Xin Xu, Dong-Sheng Liu, Hui-Zhen Fan, Li Yang, Kui Jiang, De-Kui Zhang, Long Xu, Jian-Hua Tang und 9 weitere

The Lancet Microbe · 2025-03 · 6 (3) · 100975

DOI: 10.1016/j.lanmic.2024.100975 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Lancet Microbe, 2025-03. Verfasst von Yi Hu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Digestive Diseases, Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanc…. Hauptthemen laut MEDLINE: Amoxicillin, Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Jiangxi Province, Huazhong University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmoxicillinHelicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsPyrrolesGastrointestinal MicrobiomeSulfonamidesHumansMaleMiddle AgedFemaleAdultAgedDrug Therapy, CombinationYoung AdultAdolescentTreatment OutcomeChinaProton Pump InhibitorsDrug Resistance, BacterialFeces

Substanzen

Amoxicillin1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamineAnti-Bacterial AgentsPyrrolesSulfonamidesProton Pump Inhibitors

Autor:innen und Institutionen

  • Jiangxi Provincial Key Laboratory of Digestive Diseases, Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Gastroenterology, Xi'an Central Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.
  • Department of Gastroenterology, The People's Hospital of Yichun City, Yichun, China.
  • Department of Gastroenterology, The Third People's Hospital of Jingdezhen, Jingdezhen, China.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Jiangxi Province
  • Huazhong University of Science and Technology
  • Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province
  • University of Maryland School of Public Health
  • Nanchang University

Zitieren

APA

Hu, Y., Zhang, Z. Y., Wang, F., Zhuang, K., Xu, X., Liu, D. S., Fan, H. Z., Yang, L., Jiang, K., Zhang, D. K., Xu, L., Tang, J. H., Liu, X. M., He, C., Shu, X., Xie, Y., Lau, J. Y. W., Zhu, Y., Du, Y. Q., …, & Lu, N. H. (2025). Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial. The Lancet Microbe, 6(3), 100975. https://doi.org/10.1016/j.lanmic.2024.100975

Vancouver

Hu Y, Zhang ZY, Wang F, Zhuang K, Xu X, Liu DS, et al. Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial. The Lancet Microbe. 2025;6(3):100975. doi:10.1016/j.lanmic.2024.100975

BibTeX
@article{Hu2025,
  author = {Hu, Yi and Zhang, Zhen-Yu and Wang, Fen and Zhuang, Kun and Xu, Xin and Liu, Dong-Sheng and Fan, Hui-Zhen and Yang, Li and Jiang, Kui and Zhang, De-Kui and Xu, Long and Tang, Jian-Hua and Liu, Xue-Mei and He, Cong and Shu, Xu and Xie, Yong and Lau, James Y W and Zhu, Yin and Du, Yi-Qi and Graham, David Y and Lu, Nong-Hua},
  title = {Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial},
  journal = {The Lancet Microbe},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {100975},
  doi = {10.1016/j.lanmic.2024.100975}
}
Kostenlos starten →